Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3. [electronic resource]
Producer: 20170515Description: 1453-61 p. digitalISSN:- 1440-1746
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Anticarcinogenic Agents -- pharmacology
- Azoxymethane
- Cell Transformation, Neoplastic -- drug effects
- Colitis -- chemically induced
- Colon -- drug effects
- Colorectal Neoplasms -- etiology
- Dextran Sulfate
- Disease Models, Animal
- Gastrointestinal Agents -- pharmacology
- Inflammation Mediators -- metabolism
- Interleukin-6 -- metabolism
- Macrophages -- drug effects
- Male
- Mesalamine -- pharmacology
- Mice, Inbred C57BL
- Phenylhydrazines -- pharmacology
- Phosphorylation
- Probiotics -- pharmacology
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- STAT3 Transcription Factor -- metabolism
- Signal Transduction -- drug effects
- Time Factors
- bcl-2-Associated X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.